Director/PDMR Shareholding

Biopharma Credit

01/06/2026 16:51

RNS Number : 5319G
  
BioPharma Credit PLC
  
01 June 2026
  
 


BIOPHARMA CREDIT PLC
 
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
 




1.


Details of person discharging managerial responsibilities/person closely associated with them




a)


Name


Anita Hyman




2.


Reason for the notification




a)


Position / status


Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)




b)


Initial notification / amendment


Initial notification




3.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


BioPharma Credit PLC




b)


LEI


213800AV55PYXAS7SY24




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument
 
Identification Code


Ordinary Shares of $0.01 each
 
 
GB00BDGKMY29




b)


Nature of the transaction


Purchase of Shares (acquired as part of dividend reinvestment)




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£0.71603


75









d)


Aggregated information
- Aggregated volume
 
- Price


 
 
N/A
 
 




e)


Date of the transaction


29/05/2026




f)


Place of the transaction


London Stock Exchange (XLON)










 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBUGDLCSGDGLB